Form 4: cbdMD Director William F. Raines III Acquires 75,000 Shares Through Proxy Agreement

Director William F. Raines III acquired 75,000 shares of cbdMD, Inc. through a proxy agreement related to a settlement with CBD Industries, LLC and Majik Medicine, LLC.

Summary

• William F. Raines III, a director of cbdMD, Inc., acquired 75,000 shares of common stock on August 23, 2024.
• The acquisition was made through a proxy agreement as part of a Settlement, Purchase and Release Agreement with CBD Industries, LLC and Majik Medicine, LLC.
• Raines is now the attorney, agent, and proxy for Majik Medicine, LLC for the issuance of these 75,000 shares for 12 months.
• During this period, Raines has the power to vote the shares, execute documents related to corporate affairs, and act on matters relating to the issuer, but must vote in accordance with the recommendation of a majority of the independent members of the Issuer's Board of Directors.
• Following the transaction, Raines directly owns 84,256 shares of cbdMD, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction disclosure. The proxy agreement adds a layer of complexity, but the overall impact is not clearly positive or negative.

Positives

• The acquisition increases Raines' stake in the company, potentially aligning his interests further with those of other shareholders.
• The proxy agreement ensures that the 75,000 shares will be voted in accordance with the recommendation of a majority of the independent members of the Issuer's Board of Directors.

Industry Context

Form 4 filings are standard disclosures for insiders buying or selling company stock, providing transparency to the market.

Related Party Transactions

• The Settlement, Purchase and Release Agreement between the Issuer, CBD Industries, LLC and Majik Medicine, LLC constitutes a related party transaction.

Stakeholder Impact

• The transaction could have a minor impact on shareholders by increasing insider ownership and potentially aligning interests.
• The proxy agreement ensures that the shares will be voted in accordance with the recommendation of a majority of the independent members of the Issuer's Board of Directors.

Key Dates

Keywords

cbdMD, William F. Raines III, proxy agreement, share acquisition, Form 4, YCBD, director, CBD Industries, Majik Medicine, settlement